• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

Probiotics an Adjuvant in The Management of Recurrent Aphthous Ulcer: A Randomized Clinical Trial

    Dr. Devashree Shukla, Dr. Kaushal Pati Tripathi, Dr. Ankit Dhimole, Dr. Dilraj Singh, Dr. Chandresh Shukla, Dr. Ayushi Sharma

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 2488-2493

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Recurrent Aphthous Stomatitis (RAS) is a kind of benign mouth ulceration. RAS is one of the most prevalent ulcers, affecting around 20% of the population. The goal of this study was to assess the effectiveness of probiotics on RAS.
Materials and Procedures: A total of forty people were divided into two groups. For 7 days, 20 patients in Group 1 were given Bacillus coagulans (Sporolac) and Tetracycline capsules 250 mg (Resteclin) twice daily. For 7 days, Group 2 patients were given just Tetracycline capsules 250 mg (Resteclin) twice daily. At the baseline, 4th, and 7th days, pain, size, and average duration of the ulcer were assessed. For statistical Analysis, The Mann Whitney U test was used to compare the parameters between the two groups.
Results: In just four days, the Probiotic group saw a substantial drop in all of the metrics.
Conclusion: Probiotics are used in the treatment and management of RAS as an adjuvant therapy.
Keywords:
    Aphthous ulcers Probiotics tetracyclines
  • PDF (115 K)
  • XML
(2022). Probiotics an Adjuvant in The Management of Recurrent Aphthous Ulcer: A Randomized Clinical Trial. European Journal of Molecular & Clinical Medicine, 9(3), 2488-2493.
Dr. Devashree Shukla, Dr. Kaushal Pati Tripathi, Dr. Ankit Dhimole, Dr. Dilraj Singh, Dr. Chandresh Shukla, Dr. Ayushi Sharma. "Probiotics an Adjuvant in The Management of Recurrent Aphthous Ulcer: A Randomized Clinical Trial". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 2488-2493.
(2022). 'Probiotics an Adjuvant in The Management of Recurrent Aphthous Ulcer: A Randomized Clinical Trial', European Journal of Molecular & Clinical Medicine, 9(3), pp. 2488-2493.
Probiotics an Adjuvant in The Management of Recurrent Aphthous Ulcer: A Randomized Clinical Trial. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 2488-2493.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 52
  • PDF Download: 150
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus